Zimmer Biomet Holdings Inc. plans to unveil new clinical and operational data and showcase its newest innovations next week at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting in New Orleans. Chief Movement Officer Arnold Schwarzenegger will take center stage on March 5 as the conference’s Presidential Guest Speaker.

At 10:30 a.m. (Central Time), Schwarzenegger will join Zimmer Biomet Chairman, President and CEO Ivan Tornos and AAOS President Ned Amendola, M.D., for a main-stage conversation about sustaining peak performance, teamwork, and thriving under pressure.

“Our presence at the AAOS Annual Meeting will highlight Zimmer Biomet’s leadership in orthopedic implants coupled with the robotic and digital technologies that collect data before, during and after surgery to provide insights that help surgeons understand the potential impact of surgical decisions on patient outcomes,” Tornos stated. “In addition to the technologies we plan to showcase and new data being presented, we are very proud to feature Chief Movement Officer Arnold Schwarzenegger as the Presidential Guest Speaker, and I look forward to joining him and Dr. Amendola for an engaging discussion.”

The company will highlight its various orthopedic innovations and solutions at booth 4239, including its most differentiated technologies that have built a reputation as the “Magnificent Seven,” including:

• Robotics and navigation technologies: From computed tomography (CT) to imageless to handheld robotics and AI-driven navigation technologies, Zimmer Biomet offers orthopedic robotics and navigation technologies designed to elevate surgical precision and transform patient outcomes.
• ROSA Knee with OptimiZe: The newest version of the ROSA Knee System customizes and enhances the surgeon’s experience with personalized and intelligent surgical planning, new positioning, tracking, and alignment features to improve accuracy¹ and reduce user variability²—and offers the industry’s only automated kinematic alignment feature to resurface the knee to restore its pre-arthritic position and native joint lines.
• TMINI Miniature Robotic System: A state-of-the-art miniature, handheld, wireless CT-based robotic system designed to enable accurate and precise³ implant placement.
• Monogram Technologies TKA System: A CT-based, semi-autonomous, total knee arthroplasty (TKA) robotic technology that received U.S. Food and Drug Administration (FDA) 510(k) clearance in March 2025. A surgeon-guided, fully autonomous version of this technology is currently in clinical trials.
• OrthoGrid Hip AI: An artificial intelligence (AI)-powered, fluoroscopy-based technology that provides hip surgeons with intuitive and instantaneous intra-operative tools to assist surgeons in achieving the desired surgical outcomes for component positioning.⁴
• Oxford Cementless Partial Knee: Celebrating 50 years of clinical heritage, the Oxford Partial Knee is the world’s most widely used⁵ and clinically proven^6,7 partial knee system. It is also the only FDA-approved mobile cementless partial knee implant in the United States that is efficient^8,9 in the operating room and has excellent survivorship^10,11 worldwide.
• Z1 Femoral Hip System: Offers an expansive size range and three distinct neck options designed to address various patient anatomies and reconstructive needs.
• Persona IQ The Smart Knee: The first and only smart knee implant that captures patient-specific gait and range of motion metrics directly from the knee during patient monitoring to provide post-operative recovery insights^12,13 and trends, allowing care teams to monitor and personalize the TKA patient experience.^10-14
• Persona OsseoTi Keel Tibia: A cementless tibia for TKA with a 3D printed porous tray that provides stable initial and biological fixation and intra-operative versatility.¹⁵
• HAMMR Automated Hip Impaction System: Designed to address surgeon strain, fatigue, and repetitive motion associated with the traditional mallet during hip replacement procedures, and provides a consistent, controlled, and precise energy¹⁶ designed to minimize variability in both bone preparation and device implantation.
• Persona Revision Knee System: Expands the Persona Knee System to provide a portfolio of personalized knee care to replicate a patient’s anatomy and offer an individualized fit in partial, primary, and revision knee arthroplasties.

New data being presented at the conference will highlight:

• Safety and efficacy data for the Oxford Cementless Partial Knee;
• Efficiency improvement metrics when implementing new processes and workflows in ambulatory surgery centers (ASCs);
• The relationship between early gait decline (collected with a smart implantable device) and periprosthetic joint infections in total knee arthroplasty (TKA);
• The relationship between qualified step counts (collected with a smart implantable device) and venous thromboembolisms (blood clots) following primary TKA;
• How the use of a smart implantable device and a digital care platform was associated with lower post-operative complications in knee replacement procedures;
• The association between 90-day readmissions and immediate post-operative qualified step counts (collected with a smart implantable device) following primary TKA; and
• New thresholds for post-operative gait metrics to help assess clinical significance in joint replacement patients.

Zimmer Biomet’s exhibit will also feature the latest innovations in shoulder reconstruction, sports medicine, trauma, foot and ankle reconstruction from the company’s recent Paragon 28 acquisition, along with solutions for infection prevention and the company’s ZBX Ambulatory Surgery Center Solutions (ASCs)—a comprehensive approach to help surgeons locate, design, build, and operate ASCs.

Zimmer Biomet is a global medical technology firm developing products and integrated digital and robotic technologies that leverage data, data analytics, and artificial intelligence. With more than 90 years of leadership and proven expertise, Zimmer Biomet maintains operations in over 25 countries and sells its wares in 100-plus countries.

Persona IQ: The objective kinematic data generated by the CSE with CHIRP System are not intended to support clinical decision-making and have not been shown to provide any clinical benefit.

References
¹ Data on File. DVaR-DS250106-01 ROSA Knee System v1.5 Validation Report.
² Data on File. FER-EMS230714-01 Formative Evaluation Report – July Lab 2023.
³ Data on file at THINK Surgical. 2024. Data is based on TMINI System assisted placement of cut guide compared to planned placement.
⁴ Cardenas JM, Gordon D, Waddell BS, Kitziger KJ, Peters PC Jr, Gladnick BP. Does Artificial Intelligence Outperform Humans Using Fluoroscopic-Assisted Computer Navigation for Total Hip Arthroplasty? Arthroplasty Today. 2024 May 27;27:101410. doi: 10.1016/j.artd.2024.101410. PMID: 38840694; PMCID: PMC11150909.
⁵ Data on file at Zimmer Biomet. Based on Market Analysis and Registry Data, gathered September 2017.
⁶ Price, A. and Svard, U. A Second Decade Lifetable Survival Analysis of the Oxford Unicompartmental Knee Arthroplasty. Clin Orthop Relat Res. 2011 Jan;469(1): 174-9.
⁷ Pandit et al. The clinical outcome of minimally invasive phase 3 Oxford unicompartmental knee arthroplasty. Bone Joint J 2015;97-B:1493–1500.
⁸ Pandit, H., et al. “Improved fixation in cementless unicompartmental knee replacement: five-year results of a randomized controlled trial.” JBJS 95.15 (2013): 1365-1372.
⁹ Stempin R, Kaczmarek W, Stempin K, Dutka J. Midterm Results of Cementless and Cemented Unicondylar Knee Arthroplasty with Mobile Meniscal Bearing: A Prospective Cohort Study. Open Orthop J. 2017 Oct 31;11:1173-1178. doi: 10.2174/1874325001711011173. PMID: 29290853; PMCID: PMC5721307.
¹⁰ NJR- UK . The National Joint Registry 22nd Annual Report 2025 London, 2024 [Available from: https://reports.njrcentre.org.uk/Portals/0/PDFdownloads/NJR%2022nd%20Annual%20Report%202025_Knees.pdf.
¹¹ AOANJRR. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Hip, Knee & Shoulder Arthroplasty: 2023 Annual Report Adelaide, AOA2024 [updated 2024. Available from: https://aoanjrr.sahmri.com/documents/10180/1798900/AOANJRR+2024+Annual+Report.pdf/9d0bfe03-2282-8fc8-a424-b8d9abb82b1f?t=1727666185313.
¹² Cushner FD, Yergler J, ElashoffB, Aubin PM, VertaP, Scuderi GR. Staying Ahead of the Curve: The Case for Recovery Curves in Total Knee Arthroplasty. The Journal of Arthroplasty. 2024;doi:10.1016/j.arth.2024.07.039
¹³ Cushner FD, Sculco PK, Long WJ. The Talking Knee Is a Reality: What Your Knee Can Tell You After Total Knee Arthroplasty. J OrthopaedicExperience and Innovation. 2022;2022
¹⁴ Cushner FD, Schiller P, Gross J, Mueller JK, Hunter W. A Total Knee Arthroplasty Prosthesis Capable of Remote Patient Monitoring. OrthopaedicProceedings. 2021/06/01 2021;103-B(SUPP_9):18-18 doi:10.1302/1358-992X.2021.9.018
¹⁵ Mueller J.K., et al. Persona OsseoTi Keel Tibia Provides Stable Initial Fixation 4027.2-GLBL-en. November 2022.
¹⁶ Data on File at Zimmer Biomet. Zimmer HAMMR Verification Test Report. DOC0179677. Pages 47-49. January 19, 2024.